Home » Topics » Regulatory

Regulatory
RSS

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

New Zomig formulation receives European regulatory approval

Nov. 25, 1999

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Nov. 23, 1999

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

BMS seeks approval in U.S. for Glucophage XR tablets

Nov. 22, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Ciba Vision introduces ocular formulation of lomefloxacin in U.K.

Nov. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.